Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein

By Moriya O.   Matsui M.   Osorio M.   Miyazawa H.   Rice C.M.   Feinstone S.M.   Leppla S.H.   Keith J.M.   Akatsuka T.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 789-796

Elsevier

Access to resources Recommend Favorite

Induction of T 1 (cytotoxic lymphocyte) and/or T 2 (antibody) responses to a mucin-1 tumour antigen

By Lofthouse S.A.   Apostolopoulos V.   Pietersz G.A.   Wenjun L.   McKenzie I.F.C.  

Vaccine, Vol. 15, Iss. 14, 1997-10 ,pp. : 1586-1593

Elsevier

Access to resources Recommend Favorite

Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice

By Mauch C.   Grimm C.   Meckel S.   Wands J.R.   Blum H.E.   Roggendorf M.   Geissler M.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 170-180

Elsevier

Access to resources Recommend Favorite

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite

In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses

By Cho H.-I.   Kim H.-J.   Oh S.-T.   Kim T.-G.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 224-236

Elsevier

Access to resources Recommend Favorite